The Download: OpenAI is building a fully automated researcher, and a psychedelic trial blind spot

OpenAI is embarking on a new challenge to create a fully automated AI researcher capable of solving complex problems independently. The company plans to unveil an autonomous AI research intern by September, leading up to a multi-agent system in 2028. Meanwhile, studies reveal the challenges in researching psychedelic drugs despite growing interest in their therapeutic potential. OpenAI is also developing a "super app" by merging ChatGPT, a web browser, and a coding tool, while making strategic moves in the enterprise market.